Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Cancer type-specific variation in patterns of driver alterations across 50,000 tumors.
Journal: Cancer cell
Published: April 19, 2026
The pan-tumor landscape, allelic status, and genomic complexity of SMARCA4 alterations.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 30, 2026
Allele-specific HLA LOH in solid tumors: distinct patterns by tumor type and potential prognostic relevance.
Journal: Journal for immunotherapy of cancer
Published: August 01, 2025
Prenatal Cell-Free DNA Sequencing and Intrahepatic Cholangiocarcinoma.
Journal: JCO precision oncology
Published: June 11, 2025
Next-Generation Sequencing for HLA Genotype Screening and Matching to HLA-Restricted Therapies.
Journal: JAMA oncology
Published: November 27, 2024
Cancer type-specific variation in patterns of driver alterations across 50,000 tumors.
Journal: Cancer cell
Published: April 26, 2024
CAR-engineered lymphocyte persistence is governed by a FAS ligand/FAS auto-regulatory circuit.
Journal: bioRxiv : the preprint server for biology
Published: March 11, 2024
CAR-engineered lymphocyte persistence is governed by a FAS ligand-FAS autoregulatory circuit.
Journal: Nature cancer
Published: February 23, 2024
Matrix Screen Identifies Synergistic Combination of PARP Inhibitors and Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors in Ewing Sarcoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 17, 2017
Selective inhibitors of trypanosomal uridylyl transferase RET1 establish druggability of RNA post-transcriptional modifications.
Journal: RNA biology
Published: January 21, 2016
Last Updated: 09/26/2026